Natriuretic Peptides and Metabolic Risk in Obesity
Status:
Withdrawn
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The investigators are examining:
1. the relationships of insulin levels and natriuretic peptide hormone levels, and
2. the effects of administering an infusion of natriuretic peptide hormone on the breakdown
of fat
in healthy lean and otherwise healthy obese individuals.
Phase:
Early Phase 1
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center